Device therapy is a nonpharmacological approach that presents a crucial advancement for
managing patients with atrial fibrillation (AF) and heart failure with preserved ejection …

Background Pulsed‐field ablation (PFA) has emerged as an innovative alternative to
radiofrequency (RF) and cryoablation because it selectively targets myocardial tissue. Thus …

Background Recurrence during the 3-month blanking period after radiofrequency ablation of
atrial fibrillation (AF) is typically not considered as a predictor for late recurrence. Objective …

Background Pulsed field ablation (PFA) is a novel, largely nonthermal ablative modality that,
by virtue of its putative preferential action on myocardial tissue through the process of …

Electroporation is used in medicine for drug and gene delivery, and as a nonthermal
ablation method in tumor treatment and cardiac ablation. Electroporation involves delivering …

Background The incidence of atrioventricular conduction system damage during the catheter
ablation procedure has long been a safety concern in patients with atrioventricular nodal re …

Background Pulsed field ablation, as a non-thermal ablation modality, has received
increasing attention. The aim of this study is to explore whether a reversible pulsed electric …

Cardiac magnetic resonance (CMR) imaging is a valuable noninvasive tool for evaluating
tissue response following catheter ablation of atrial tissue. This review provides an overview …

PFA uses short-duration, high-voltage electrical pulses to induce transient or irreversible
electroporation on cell membranes, causing cell death. Selective inhibition of chaotic …

Background Radiofrequency catheter ablation (RFCA) may lead to decreased quality of life
(QOL) and increased anxiety and depression in patients with paroxysmal supraventricular …